Adam Oliensis Highlights the Following Stocks: AT&T, Amgen, EBAY, Nextel, Pfizer, Morgan Stanley, and Krispy Kreme.Business Editors CHICAGO--(BUSINESS WIRE)--April 25, 2003 Pull over to the side of the road and use Adam Oliensis' Sentiment Dashboard to map out your path to profits. He also has several unique stock commentaries that could help you on your trip. Get his takes on AT&T (NYSE NYSE See: New York Stock Exchange :T), Amgen (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :AMGN), EBAY (NASDAQ:EBAY), Nextel (NASDAQ:NXTL), Pfizer (NYSE:PFE 1. (text, editor) PFE - Programmer's File Editor. 2. (language) PFE - Portable Forth Environment. ), Morgan Stanley (NYSE:MWD MWD Metropolitan Water District of Southern California MWD Measurement While Drilling (oil drilling) MWD Morgan Stanley Dean Witter (stock symbol) MWD Molecular Weight Distribution MWD Military Working Dog ), and Krispy Kreme (NYSE:KKD KKD Kultur- og Kirkedepartementet (Norwegian: Ministry of Culture and Church Affairs) KKD Krispy Kreme Doughnuts (stock symbol) KKD Kilocalories per Kilogram of body weight Per Day ). Click here for the full story exclusively on Zacks.com: http://featuredexpert2bw.zacks.com/ Here are the highlights from the Featured Expert column: BOTTOM LINE: Is Adam Oliensis seduced by the bullish ambiance am·bi·ance also am·bi·ence n. The special atmosphere or mood created by a particular environment: "The noir ambience is dominated by low-key lighting . . . ? You bet. He loves nothing so much as a good tech rally. But the reality is that the tank has drained from 85% down to 8%. Could it be different this time? Could be. But more likely this rally will run out of sentiment fuel, and pretty darn soon. Oliensis is humbled by Wednesday's actions that took him out of his DIA and QQQ QQQ The Nasdaq-100 Index Tracking Stock. This is a tracking stock which trades like an index mutual fund which follows the Nasdaq 100 index. It trades continuously. QQQ shorts. So, he'll have to look for the actual sell signal before he shorts the broad market again. The stocks with the largest OVM OVM Open Verification Methodology OVM Organic Vapor Monitor OVM Organic Vapor Meter OVM Offender Victim Ministries OVM Overflow Mode OVM Operation Vigilant Mariner OVM Operators Vehicle Maintenance OVM Oracle Virtual Machine OVM Out-of-Order Parallel Virtual Machine Surge Factor had the largest surges. AT&T (NYSE:T), Amgen (NASDAQ:AMGN), EBAY (NASDAQ:EBAY), and Nextel (NASDAQ:NXTL) are all crazy overbought Overbought A technical analysis term describing a situation where a security has risen to such a price, usually on high volume, that an oscillator has reached its upper bound. . They may continue on up, but they don't provide interesting loss cut puts. Pfizer (NYSE:PFE) also looks weak and could be an interesting short if Oliensis gets that market sell signal. Morgan Stanley (NYSE:MWD) has terrifically strong charts. That doesn't mean it's time to short them, necessarily, but he'll watch them for periods of retracement Retracement A reversal in the movement of a stock's price, countering the prevailing trend. ![]() Notes: An example might be market risk causing a stock's price to pull back. . Krispy Kreme (NYSE:KKD) is a highly valued donut shop. The chain has enjoyed impressive growth, but if that growth were to begin to disappoint, the stock is probably vulnerable. The stock suffers extremely high short interest, with over 17 days' worth of volume in open short positions. So, you don't want to be on the wrong side of this short if it starts to move up because you'll have a lot of company when you try to cover your position. Keep tabs on Adam Oliensis' Sentiment Dashboard on a daily basis, and don't forget to view his OVM chart and read his complete commentaries by clicking: http://featuredexpert3bw.zacks.com/ About Zacks Featured Experts To be a successful investor you need professional advice. Experts who know what they're talking about and can help you achieve your financial goals in good markets...and especially in bad ones will help you improve your portfolio. That is why Zacks Investment Research Zacks Investment Research A firm that compiles earnings estimates and brokerage firm investment recommendations for thousands of publicly traded firms. has assembled the best investment experts in the business to offer their powerful advisory newsletters to you on all the major investment topics: Stocks, Mutual Funds, Bonds, Options, Futures etc. Recommendations from Featured Experts Highlighted in FREE Investment Newsletter The best way to tap into the powerful advice from these experts is through our free weekly e-mail newsletter, "Profit from the Pros". Each week we highlight several Featured Experts in this free e-mail newsletter. Get your free subscription to "Profit from the Pros" at: http://www.freeprofit1bw.zacks.com About Zacks Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1981 to compile, analyze, and distribute investment research to both institutional and individual investors. The guiding principle behind our work is the belief that investment experts, such as brokerage analysts and investment newsletter writers, have superior knowledge about how to invest successfully. Our goal is to unlock their profitable insights for our customers. And there is no better way to enjoy this investment success, than with a FREE subscription to "Profit from the Pros" weekly e-mail newsletter. For your free newsletter, visit http://www.freeprofitbw.zacks.com Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates. Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security. |
|
||||||||||||||||


Printer friendly
Cite/link
Email
Feedback
Reader Opinion